Friday, 28 July 2017

AbbVie's drug for all types of hepatitis C wins EU approval

(Reuters) - AbbVie Inc said on Friday it had received European approval to market its drug for treatment of all six major forms of hepatitis C.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)